Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ROIC - WACC | 6.2% | 8.9% | 5.0% | 8.3% | 12.5% | 16.0% | 16.3% | 11.5% | 14.6% | 12.8% | 10.8% | 15.9% | 19.1% | 2.9% | 23.0% | 17.2% | 7.6% | 8.2% | 4.5% | 5.9% |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Microsoft Corp's last 12-month ROIC - WACC is 3.0%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual ROIC - WACC for Amgen Inc. have been 9.3% over the past three years, and 12.0% over the past five years.
As of today, Amgen Inc.'s ROIC - WACC is 3.0%, which is lower than industry median of 8.9%. It indicates that Amgen Inc.'s ROIC - WACC is Bad.